Vincent O'Neill - Executive Vice President, Chief of Product Development and Medical Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President, Chief of Product Development and Medical Officer
Issuer Symbol
BTAI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Vincent O'Neill since 03 Feb 2025

Holdings reported by Vincent O'Neill for BioXcel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19,957 $7,031 $0.3523 16 Dec 2024 Direct
Restricted Stock Units 2,606 $944 $0.3624 14 Dec 2024 Direct Common Stock
Stock Option (right to buy) 1,875 22 Jul 2024 Direct Common Stock 0

Transactions reported by Vincent O'Neill for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.